Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer
- First Posted Date
- 2016-04-25
- Last Posted Date
- 2016-04-25
- Lead Sponsor
- Pharmatech
- Target Recruit Count
- 41
- Registration Number
- NCT02749825
- Locations
- ๐บ๐ธ
Jazrawi-Atallah, P.C., Brooklyn, New York, United States
๐บ๐ธAlbemarle Urology Clinic, PA, Albemarle, North Carolina, United States
๐บ๐ธRaj P. Chopra MD, PC, Bloomsburg, Pennsylvania, United States
Characterization of Human Cancers by Molecular Profiling of Patient Biospecimens
- Conditions
- Cancer
- First Posted Date
- 2016-04-25
- Last Posted Date
- 2016-04-25
- Lead Sponsor
- Pharmatech
- Target Recruit Count
- 183
- Registration Number
- NCT02749838
- Locations
- ๐บ๐ธ
Pharmatech Inc., Denver, Colorado, United States
Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Phase 2
Completed
- Conditions
- Diffuse Large B-Cell Lymphoma
- Interventions
- First Posted Date
- 2009-01-29
- Last Posted Date
- 2016-04-19
- Lead Sponsor
- Pharmatech
- Target Recruit Count
- 61
- Registration Number
- NCT00831597
- Locations
- ๐บ๐ธ
Pharmatech Oncology Study Site, Richardson, Texas, United States
Phase II Avastin Trial for Stage IIIB/IV NSCLC
Phase 2
Terminated
- Conditions
- Non-small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IV
- Interventions
- First Posted Date
- 2008-10-03
- Last Posted Date
- 2016-04-19
- Lead Sponsor
- Pharmatech
- Target Recruit Count
- 125
- Registration Number
- NCT00766246
ยฉ Copyright 2025. All Rights Reserved by MedPath